Prediction of Lymphovascular and Perineural Invasion of Oral Squamous Cell Carcinoma by Combined Expression of p63 and Cyclin D1

Abstract

Objectives The aim of this study was to determine the value of immune expression of p63 and cyclin D1 in the prediction of lymphovascular invasion (LVI) and perineural invasion (PNI) in oral squamous cell carcinoma (OSCC).

Materials and Methods Clinical and histopathologic features of 65 subjects with histologically confirmed OSCC were collected. Tissue microarray blocks representing all subjects were prepared for the immunohistochemical quantification of the nuclear expression of p63 and cyclin D1 using immune ratio plugin of image J software. Image analysis was performed by two independent pathologists. Independent samples t-test, analysis of variance, and receiver operating characteristic curve tests were used for statistical analysis. The level of significance was set at p≤ 0.05.

Results The optimum cutoff value for the prediction of LVI for p63 and cyclin D1 was found to be 100 and 93.2, respectively, while the optimum cutoff value for the prediction of PNI for p63 and cyclin D1 was found to be 95.9 and 94, respectively. p63 and cyclin D1 expression correlated with several clinicopathologic features of the studied population. p63 expression was a significant predictor of moderate/poorly differentiated OSCC compared with well-differentiated OSCC. A parallel combination of positive p63 and cyclin D1 increased the specificity of predicting LVI from 89.1% and 67.4% for either p63 or cyclin D1, respectively, to 93.5% with a positive predictive value of 92.5%. Similarly, the parallel combination of the two markers raised the specificity of predicting PNI from 70% and 77.5% for either p63 or cyclin D1, respectively, to 90% with a positive predictive value of 86.3%.

Conclusion Combined overexpression of nuclear markers p63 and cyclin D1 can be considered as a valuable independent predictor of LVI and PNI, and hence tumor progression, in OSCC.

Keywords

p63 - cyclin D1 - lymphovascular invasion - perineural invasion - tissue microarray - oral squamous cell carcinoma.

Declarations

Ethical Approval and Consent to Participate

This study was supported by the Ethics committee of Tawam General Hospital and has been performed in accordance with the World Medical Association Declaration of Helsinki.

Consent for Publication

A permission was obtained from hospital authority to publish the data.

Availability of Data and Materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Conflict of interest

None declared.

Authors' Contributions

NH designed the work; MA contributed to the acquisition of the data; NH and AA helped in interpretation of data; SA, WE, and MA drafted and reviewed the draft; AA was involved in statistical analyses.

Publikationsverlauf

Artikel online veröffentlicht:
30. Januar 2023

• References

• 1 Sung H, Ferlay J, Siegel RL. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71 (03) 209-249
• 2 Murthy V, Agarwal JP, Laskar SG. et al. Analysis of prognostic factors in 1180 patients with oral cavity primary cancer treated with definitive or adjuvant radiotherapy. J Cancer Res Ther 2010; 6 (03) 282-289
• 3 Chinn SB, Myers JN. Oral cavity carcinoma: current management, controversies, and future directions. J Clin Oncol 2015; 33 (29) 3269-3276
• 4 Hosokawa Y, Arnold A. Cyclin D1/PRAD1 as a central target in oncogenesis. J Lab Clin Med 1996; 127 (03) 246-252
• 5 Todd R, Hinds PW, Munger K. et al. Cell cycle dysregulation in oral cancer. Crit Rev Oral Biol Med 2002; 13 (01) 51-61
• 6 Weinstein IB, Zhou P. Cell Cycle Control Gene Defects and Human Cancer. Encyclopedia of Cancer. 1997;Vol. 1. New York: Academic Press
• 7 Sarbia M, Stahl M, Fink U. et al. Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities. Int J Cancer 1999; 84 (01) 86-91
• 8 Patel SB, Manjunatha BS, Shah V, Soni N, Sutariya R. Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia. J Korean Assoc Oral Maxillofac Surg 2017; 43 (05) 324-330
• 9 Fisher ML, Balinth S, Mills AA. p63-related signaling at a glance. J Cell Sci 2020; 133 (17) jcs228015
• 10 Chen YK, Hsue SS, Lin LM. Expression of p63 protein and mRNA in oral epithelial dysplasia. J Oral Pathol Med 2005; 34 (04) 232-239
• 11 Schmale H, Bamberger C. A novel protein with strong homology to the tumor suppressor p53. Oncogene 1997; 15 (11) 1363-1367
• 12 Chang W-C, Chang C-F, Li Y-H. et al. A histopathological evaluation and potential prognostic implications of oral squamous cell carcinoma with adverse features. Oral Oncol 2019; 95: 65-73
• 13 Chen J-W, Xie J-D, Ling Y-H. et al. The prognostic effect of perineural invasion in esophageal squamous cell carcinoma. BMC Cancer 2014; 14 (01) 1-7
• 14 Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature. Cancer 2009; 115 (15) 3379-3391
• 15 Ling W, Mijiti A, Moming A. Survival pattern and prognostic factors of patients with squamous cell carcinoma of the tongue: a retrospective analysis of 210 cases. J Oral Maxillofac Surg 2013; 71 (04) 775-785
• 16 Zhu Y, Liu H, Xie N. et al. Impact of tumor budding in head and neck squamous cell carcinoma: a meta-analysis. Head Neck 2019; 41 (02) 542-550
• 17 Mitani S, Tomioka T, Hayashi R, Ugumori T, Hato N, Fujii S. Anatomic invasive depth predicts delayed cervical lymph node metastasis of tongue squamous cell carcinoma. Am J Surg Pathol 2016; 40 (07) 934-942
• 18 Fives C, Feeley L, O'Leary G, Sheahan P. Importance of lymphovascular invasion and invasive front on survival in floor of mouth cancer. Head Neck 2016; 38 (Suppl. 01) E1528-E1534
• 19 Herman CM, Wilcox GE, Kattan MW, Scardino PT, Wheeler TM. Lymphovascular invasion as a predictor of disease progression in prostate cancer. Am J Surg Pathol 2000; 24 (06) 859-863
• 20 Jiang H-H, Zhang Z-Y, Wang X-Y. et al. Prognostic significance of lymphovascular invasion in colorectal cancer and its association with genomic alterations. World J Gastroenterol 2019; 25 (20) 2489-2502
• 21 Huang S, Zhu Y, Cai H, Zhang Y, Hou J. Impact of lymphovascular invasion in oral squamous cell carcinoma: a meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol 2021; 131 (03) 319-328.e1
• 22 Varghese F, Bukhari AB, Malhotra R, De A. IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS One 2014; 9 (05) e96801
• 23 Weng X, Liu Y, Ma J, Wang W, Yang G, Caballero B. Use of body mass index to identify obesity-related metabolic disorders in the Chinese population. Eur J Clin Nutr 2006; 60 (08) 931-937
• 24 Westfall MD, Pietenpol JA. p63: Molecular complexity in development and cancer. Carcinogenesis 2004; 25 (06) 857-864
• 25 Oliveira LR, Ribeiro-Silva A, Zucoloto S. Prognostic significance of p53 and p63 immunolocalisation in primary and matched lymph node metastasis in oral squamous cell carcinoma. Acta Histochem 2007; 109 (05) 388-396
• 26 Haddad RI, Shin DM. Recent advances in head and neck cancer. N Engl J Med 2008; 359 (11) 1143-1154
• 27 Rapidis AD, Givalos N, Gakiopoulou H. et al. Adenoid cystic carcinoma of the head and neck. Clinicopathological analysis of 23 patients and review of the literature. Oral Oncol 2005; 41 (03) 328-335
• 28 Fagan JJ, Collins B, Barnes L, D'Amico F, Myers EN, Johnson JT. Perineural invasion in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1998; 124 (06) 637-640
• 29 Soo KC, Carter RL, O'Brien CJ, Barr L, Bliss JM, Shaw HJ. Prognostic implications of perineural spread in squamous carcinomas of the head and neck. Laryngoscope 1986; 96 (10) 1145-1148
• 30 Rahima B, Shingaki S, Nagata M, Saito C. Prognostic significance of perineural invasion in oral and oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 97 (04) 423-431
• 31 Woolgar JA. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol 2006; 42 (03) 229-239
• 32 Larsen SR, Johansen J, Sørensen JA, Krogdahl A. The prognostic significance of histological features in oral squamous cell carcinoma. J Oral Pathol Med 2009; 38 (08) 657-662
• 33 An SY, Jung EJ, Lee M. et al. Factors related to regional recurrence in early stage squamous cell carcinoma of the oral tongue. Clin Exp Otorhinolaryngol 2008; 1 (03) 166-170
• 34 Sethi S, Lu M, Kapke A, Benninger MS, Worsham MJ. Patient and tumor factors at diagnosis in a multi-ethnic primary head and neck squamous cell carcinoma cohort. J Surg Oncol 2009; 99 (02) 104-108
• 35 Sinha A, Chandra S, Raj V, Zaidi I, Saxena S, Dwivedi R. Expression of p63 in potentially malignant and malignant oral lesions. J Oral Biol Craniofac Res 2015; 5 (03) 165-172
• 36 Ting K-C, Lee T-L, Li W-Y. et al. Perineural invasion/lymphovascular invasion double positive predicts distant metastasis and poor survival in T3-4 oral squamous cell carcinoma. Sci Rep 2021; 11 (01) 19770
• 37 Do Valle IB, Damasceno TCD, Pansini PF. et al. p63 expression in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol 2018; 126 (03) e178
• 38 Bortoluzzi MC, Yurgel LS, Dekker NP, Jordan RCK, Regezi JA. Assessment of p63 expression in oral squamous cell carcinomas and dysplasias. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98 (06) 698-704
• 39 Marx J. How cells cycle toward cancer. Science 1994; 263 (5145): 319-321
• 40 Huang S-F, Cheng S-D, Chuang W-Y. et al. Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma. World J Surg Oncol 2012; 10 (01) 40
• 41 Bova RJ, Quinn DI, Nankervis JS. et al. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin Cancer Res 1999; 5 (10) 2810-2819
• 42 Kaminagakura E, Werneck da Cunha I, Soares FA, Nishimoto IN, Kowalski LP. CCND1 amplification and protein overexpression in oral squamous cell carcinoma of young patients. Head Neck 2011; 33 (10) 1413-1419